Latest News & Features

Reset all filters
Channels & Sectors
Geography
Company
Refine search
Lululemon beats Nike after judge kicks out $355k Flyknit verdict
Patents
A US judge has sided with the Canadian ‘athleisure’ brand in its running-shoe feud, overturning a jury verdict from a year ago by finding Nike’s patent obvious.   1 April 2026
Squire Patton Boggs names new European managing partner
Careers
A long-serving partner in the IP & technology division will head up the European practice at the firm.   1 April 2026
GlobalBlock adds world's two largest country domains—centralised brand protection in more than 750 web extensions
Trademarks
Addition of China's .cn and Germany's .de marks a major milestone in simplifying global IP protection, says Tony Kirsch of the Brand Safety Alliance.   1 April 2026
Trademarks
The French luxury and cosmetics groups both successfully opposed registrations that encroached on their signs in EU territories.   1 April 2026
Trademarks
A solo entrepreneur has beaten a billion-dollar brand in a trademark trial. BraunHagey & Borden’s counsel reveals the strategies that secured a decisive victory.   31 March 2026
Patents
The largest solar manufacturer in the US is seeking the Commission’s most powerful remedy against 47 companies that it says are importing infringing PV components.   30 March 2026
Careers
The new IP chief joined the firm in 2025 and replaces Mary Bagnall, who spent nearly a decade in the role and will become a consultant to the firm.   30 March 2026
In-House
New for this year, the vetted list celebrates leading in-house counsel who demonstrate exceptional ability in managing their organisation's IP portfolio, legal team, and IP culture.   27 March 2026
Patents
The European Court of Justice will decide how far the UPC’s ‘long-arm’ jurisdiction can reach in a complex case brought by Dyson, the outcome of which could have a far-reaching impact on businesses. Sarah Speight explores.   27 March 2026
Jurisdiction reports
The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.   27 March 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.